Analyst Price Targets — PDS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 2, 2026 3:41 pm | Sergey Pigarev | Loop Capital Markets | $122.00 | $88.49 | StreetInsider | Precision Drilling (PDS) PT Raised to $122 at Freedom Capital Markets |
| February 17, 2026 12:01 pm | — | Piper Sandler | $105.00 | $87.35 | TheFly | Precision Drilling price target raised to $105 from $81 at Piper Sandler |
| December 18, 2025 11:29 am | — | Piper Sandler | $81.00 | $68.01 | TheFly | Precision Drilling price target raised to $81 from $79 at Piper Sandler |
| October 28, 2025 10:32 am | Derek Podhaizer | Piper Sandler | $79.00 | $59.05 | TheFly | Precision Drilling price target raised to $79 from $74 at Piper Sandler |
| July 14, 2025 8:18 pm | Derek Podhaizer | Piper Sandler | $72.00 | $49.78 | TheFly | Precision Drilling initiated with an Overweight at Piper Sandler |
| May 6, 2024 7:37 am | Luke Lemoine | Piper Sandler | $101.00 | $71.12 | StreetInsider | Precision Drilling (PDS) PT Raised to $101 at Piper Sandler |
| June 20, 2022 9:51 am | Ian Macpherson | Piper Sandler | $125.00 | $61.47 | Pulse 2.0 | Precision Drilling (PDS) Stock: $125 Target And Overweight Rating |
| January 27, 2022 12:00 am | John Bereznicki | Canaccord Genuity | $47.74 | $41.72 | StreetInsider | Canaccord Genuity Reiterates Hold Rating on Precision Drilling (PD:CN) (PDS) |
| January 7, 2022 12:00 am | James West | Evercore ISI | $65.25 | $41.30 | TipRanks Contributor | Precision Drilling (PDS) Received its Third Buy in a Row |
Latest News for PDS
STEP Energy Services (OTCMKTS:SNVVF - Get Free Report) and Precision Drilling (NYSE: PDS - Get Free Report) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings. Earnings and Valuation This table compares STEP
PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today provided a business and clinical programs update and reported financial results for the quarter ended June 30, 2026.
PDS Biotechnology Corporation (NASDAQ:PDSB) shares have fallen by about 67% on Tuesday as the company announced a strategic refocus on its PDS0301 program for metastatic colorectal cancer.
AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on earnings.
Dimensional Fund Advisors LP grew its holdings in Precision Drilling Corporation (NYSE: PDS) (TSE: PD) by 37.0% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 288,013 shares of the oil and gas company's stock after buying an additional 77,775 shares during the period. Dimensional Fund Advisors
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PDS.
Senate Trading
No Senate trades found for PDS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.